|
eligibility criterion
|
OBI_0500026 |
|
|
three-dimensional spatial region
|
BFO_0000028 |
|
|
site
|
BFO_0000029 |
|
|
Planned Subject Number
|
NCIT_C49692 |
|
|
zero-dimensional continuant fiat boundary
|
BFO_0000147 |
|
|
one-dimensional spatial region
|
BFO_0000026 |
|
|
object aggregate
|
BFO_0000027 |
|
|
Surgical Procedure
|
NCIT_C15329 |
|
|
medical procedure
|
OAE_0002807 |
|
|
spatiotemporal region
|
BFO_0000011 |
|
|
clinical trials registry organization
|
CTO_0000077 |
|
|
US ClinicalTrial.gov registry
|
CTO_0000076 |
|
|
Sri Lanka clinical trials registry
|
CTO_0000075 |
|
|
Peruvian clinical trial registry
|
CTO_0000074 |
|
|
drug product
|
DRON_00000005 |
|
|
diagnosis
|
OGMS_0000073 |
|
|
Expanded Access Study
|
NCIT_C98722 |
|
|
Phase I/II Trial
|
NCIT_C15693 |
|
|
Phase II/III Trial
|
NCIT_C15694 |
|
|
zero-dimensional spatial region
|
BFO_0000018 |
|
